Author

Yang Liu

Institution: Qilu Medical University

Observed institutions: Harbin Medical University, Qilu Medical University

ORCID: 0000-0002-1516-0168

Observed ORCID: 0000-0002-1516-0168

OpenAlex ID: A5001605727

Integrative network pharmacology and in silico analyses identify the anti-omicron SARS-CoV-2 potential of eugenol

2023 · Yang Liu · Heliyon · 10

Cardiovascular protective properties of the natural product eugenol

2025 · Xin-yu Liu, Yun-ke Nie, et al. · European Journal of Pharmacology · 9

Antiviral properties of the natural product eugenol: A review

2025 · Mei Chen, Yun-Ke Nie, et al. · Fitoterapia · 9

Prediction of chemotherapy-mediated cardiotoxicity in patients with cancer by cardiac troponin I: A systematic review and meta-analysis

2024 · Yang Liu, Huanglong Liu · International Journal of Risk & Safety in Medicine · 6

Transcriptome analysis of serum biomarker, shared gene signature and pharmacological targets between diabetic cardiomyopathy and nephropathy

2025 · Yang Liu, Mei Chen, et al. · Biochemistry and Biophysics Reports · 3

Short-term Effects of High Thoracic Epidural Blockade in Patients With Ischemic Heart Disease and Heart Failure: A Systematic Review and Data Synthesis

2025 · Daoyu Guo, Mei Chen, et al. · Reviews in Cardiovascular Medicine

In Silico Discovery of Small Molecule Modulators Targeting Ebola Virus VP 35 and VP 40 protein

2025 · Yang Liu, Chen Zhu, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Review of: "Targeting Alzheimer's disease hallmarks with the Nrf2 activator Isoeugenol"

2023 · Yang Liu · Qeios

Review of: "Can Urolithin A Help in Curing COVID-19 Infection?"

2023 · Yang Liu · Qeios

Works count: 9

Citation count: 37

H-index: 4

I10-index: 1